Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05969860 · ClinicalTrials.gov registry record · Phase 2
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
A Phase 2 study of Advanced Breast Carcinoma and Advanced Colorectal Carcinoma, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 220
- Enrollment target
- 2
- Study locations
NCT05969860 is a Phase 2 study of Advanced Breast Carcinoma and Advanced Colorectal Carcinoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 220 participants, above the 43-participant average among 10 other Advanced Breast Carcinoma trials with a reported enrollment target (412% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT05969860, a Phase 2 study of Advanced Breast Carcinoma and Advanced Colorectal Carcinoma, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 220 participants
- Enrollment target
- 2
- Study locations
Study Summary
This clinical trial studies the effect of cancer directed therapy given at-home versus in the clinic for patients with cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Currently most drug-related cancer care is conducted in infusion centers or specialty hospitals, where patients spend many hours a day isolated from family, friends, and familiar surroundings. This separation adds to the physical, emotional, social, and financial burden for patients and their families. The logistics and costs of navigating cancer treatments have become a principal contributor to patients' reduced quality of life. It is therefore important to reduce the burden of cancer in the lives of patients and their caregivers, and a vital aspect of this involves moving beyond traditional hospital and clinic-based care and evaluate innovative care delivery models with virtual capabilities. Providing cancer treatment at-home, versus in the clinic, may help reduce psychological and financial distress and increase treatment compliance, especially for marginalized patients and communities.
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- OTHER Home Health Encounter
- PROCEDURE Clinical Encounter
Study Locations (2)
Florida
- Mayo Clinic in Florida - Jacksonville
North Dakota
- Altru Cancer Center - Grand Forks
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2023-08-23 |
| Est. Completion | 2027-01-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05969860
The ClinicalTrials.gov registry entry for NCT05969860 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 43-participant average among 10 other Advanced Breast Carcinoma trials with a reported enrollment target (412% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Advanced Breast Carcinoma appearing as the primary indexed condition, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.
NCT05969860 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Florida, North Dakota.
Frequently Asked Questions
What is clinical trial NCT05969860 about?
NCT05969860 is a clinical study titled "At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer". This clinical trial studies the effect of cancer directed therapy given at-home versus in the clinic for patients with cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). Currently most drug-related cancer care is conducted ...
What is the current status of trial NCT05969860?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 220 participants. The study started on 2023-08-23. Estimated completion is 2027-01-01.
What conditions does trial NCT05969860 study?
This clinical trial studies the following conditions: Advanced Breast Carcinoma, Advanced Colorectal Carcinoma, Advanced Biliary Tract Carcinoma, Advanced Gastric Carcinoma, Advanced Cervical Carcinoma.
What interventions are being tested in trial NCT05969860?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Home Health Encounter (OTHER), Clinical Encounter (PROCEDURE).
Who is sponsoring clinical trial NCT05969860?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05969860 being conducted?
This trial has 2 study locations across Florida, North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Advanced Breast Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer
RECRUITING · Phase 2
-
A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer
ACTIVE NOT RECRUITING · Phase 2
-
TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer
ACTIVE NOT RECRUITING · Phase 2
-
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
RECRUITING · Phase 1
-
Living Well With Advanced Breast Cancer
RECRUITING
-
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.